A better future for women's health
Berlin will be the first hub of WomenX Collective – a new global center for advancing research, innovation and investment in women's health. This initiative aims to bridge the gap in women's health solutions by…
UNFPA, the United Nations Population Fund, will launch its new “WomenX Collective” programme at the World Health Summit in Berlin on October 14, followed the next day by the opening of its first hub office in a planned global network of centres…
Companies will collaborate to develop a high-value small molecule program, further enhancing Bayer’s precision oncology development portfolio / MOMA will receive an upfront payment and collaboration fee and is eligible to receive near-term discovery,…
Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today announced a new global clinical supply agreement.…
Constant changes in our world often lead to experiencing stress. This can negatively affect our health. However, many people do not even realize that they are in a state of stress.
Pentixapharm Holding AG (“Pentixapharm”) made its debut today in the Prime Standard of the Frankfurt Stock Exchange under the ticker symbol PTP and the international securities identification number (ISIN) DE000A40AEG0. The initial trading price was…
Breast cancer is the most common type of cancer in women. During Breast Cancer Awareness Month in October, people around the world are informed about the disease, the situation of women and prevention options. In Berlin-Brandenburg, this topic is…
Caresyntax, a leader in surgical intelligence and automation, has been awarded the prestigious 2024 German AI Prize. The awards were presented by Volker Wissing, Germany’s Federal Minister for Digitalization, at a ceremony held in Berlin on…
The Berlin-based start-up Cambrium uses artificial intelligence to produce bio-based materials. The materials are sustainable and above all - depending on the use case - adaptable to the respective purpose.
Orphan Diseases and Challenging Targets
Collaborate with venture capital and scientific experts for your drug discovery projects
